Phosphorylation of Oct-2 at sites located in the POU domain induces differential down-regulation of Oct-2 DNA-binding ability

被引:18
作者
Pevzner, V
Kraft, R
Kostka, S
Lipp, M
机构
[1] Max Delbruck Ctr Mol Med, Dept Tumorgenet & Immunogenet, D-13092 Berlin, Germany
[2] Max Delbruck Ctr Mol Med, Dept Prot Chem, D-13092 Berlin, Germany
关键词
CXCR5; gene expression; octamer sequence; okadaic acid;
D O I
10.1042/0264-6021:3470029
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We compared the effects of phosphorylation of Oct-2 protein on its binding to the consensus octamer sequence (ATGCAAAT) and two non-canonical sequences present in human (AAGCAAAT) and murine (AAACAAAT) promoters of the BLR1 (Burkitts' lymphoma receptor 1) gene encoding chemokine receptor CXCR5 (CXC-chemokine receptor 5). The latter cis-acting elements represent low-affinity recognition sequences for the octamer transcription factors. Okadaic acid was found to induce hyperphosphorylation of Oct-2 specifically in cells of lymphoid lineage. Potentially phosphorylated amino acid residues localized to the POU-specific domain of Oct-2. Whereas binding of Oct-2 to the octamer site from the human BLR1 promoter or to the consensus octamer sequence was unaffected by phosphorylation of this factor, a strong reduction of Oct-2 binding to the octamer site from the murine BLR1 promoter was observed. This finding correlates well with the down-regulation of expression of the BLR1 gene in murine splenic cells but not in lymphoid cells of human origin treated with okadaic acid. These data support the hypothesis that phosphorylation of Oct-2 may be a mechanism by which activities of the promoters containing non-canonical octamer sequences are differentially regulated in response to extracellular stimuli.
引用
收藏
页码:29 / 35
页数:7
相关论文
共 37 条
[1]   OCA-B is a functional analog of VP16 but targets a separate surface of the Oct-1 POU domain [J].
Babb, R ;
Cleary, MA ;
Herr, W .
MOLECULAR AND CELLULAR BIOLOGY, 1997, 17 (12) :7295-7305
[2]   PhosphoBase: a database of phosphorylation sites [J].
Blom, N ;
Kreegipuu, A ;
Brunak, S .
NUCLEIC ACIDS RESEARCH, 1998, 26 (01) :382-386
[3]   A TRANSCRIPTION FACTOR WHICH BINDS TO THE ENHANCERS OF SV40, IMMUNOGLOBULIN HEAVY-CHAIN AND U2 SNRNA GENES [J].
BOHMANN, D ;
KELLER, W ;
DALE, T ;
SCHOLER, HR ;
TEBB, G ;
MATTAJ, IW .
NATURE, 1987, 325 (6101) :268-272
[4]   Sequence-specific DNA binding of the B-cell-specific coactivator OCA-B [J].
Cepek, KL ;
Chasman, DI ;
Sharp, PA .
GENES & DEVELOPMENT, 1996, 10 (16) :2079-2088
[5]   DIFFERENTIATION-SPECIFIC EXPRESSION OF A NOVEL G-PROTEIN-COUPLED RECEPTOR FROM BURKITT-LYMPHOMA [J].
DOBNER, T ;
WOLF, I ;
EMRICH, T ;
LIPP, M .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1992, 22 (11) :2795-2799
[6]   PURIFICATION AND CHARACTERIZATION OF OTF-1, A TRANSCRIPTION FACTOR REGULATING CELL-CYCLE EXPRESSION OF A HUMAN HISTONE H2B GENE [J].
FLETCHER, C ;
HEINTZ, N ;
ROEDER, RG .
CELL, 1987, 51 (05) :773-781
[7]  
FORSTER R, 1994, BLOOD, V84, P830
[8]   A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen [J].
Forster, R ;
Mattis, AE ;
Kremmer, E ;
Wolf, E ;
Brem, G ;
Lipp, M .
CELL, 1996, 87 (06) :1037-1047
[9]   Oct-1 and Oct-2 DNA-binding site specificity is regulated in vitro by different kinases [J].
Grenfell, SJ ;
Latchman, DS ;
Thomas, NSB .
BIOCHEMICAL JOURNAL, 1996, 315 :889-893
[10]   The B cell coactivator Bob1 shows DNA sequence-dependent complex formation with Oct-1/Oct-2 factors, leading to differential promoter activation [J].
Gstaiger, M ;
Georgiev, O ;
vanLeeuwen, H ;
vanderVliet, P ;
Schaffner, W .
EMBO JOURNAL, 1996, 15 (11) :2781-2790